Annie Purvis

Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial

Jeffrey S. Heier, Saleema Kherani, Shilpa J. Desai et al. · The Lancet · 2017 · 220 citations

Open-label Trial, Translational Medicine, Ocular Disease +8

Postal survey of bronchoscopic practice by physicians in the United Kingdom.

F G Simpson, A G Arnold, Annie Purvis et al. · Thorax · 1986 · 209 citations · Full text

Asthma, Transbronchial Lung Biopsy, Interventional Pulmonology +14

A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis

Adam Cuker, Alasdair Coles, H. R. Sullivan et al. · Blood · 2011 · 105 citations · Full text

Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience

Sandra Vukusic, Patricia K. Coyle, Stéphanie Jurgensen et al. · Multiple Sclerosis Journal · 2019 · 68 citations

Case report of anti-glomerular basement membrane disease following alemtuzumab treatment of relapsing–remitting multiple sclerosis

David Meyer, Alasdair Coles, Pedro Oyuela et al. · Multiple Sclerosis and Related Disorders · 2012 · 39 citations

Glomerulonephritis, Autoimmune Disease, Systemic Scleroderma +8